Adalimumab trials for Psoriasis

All Adalimumab trials · All Psoriasis trials

Phase breakdown

Recruiting trials studying Adalimumab for Psoriasis

• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
  NCT06100744 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 34 locations
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Swiss Dermatology Network of Targeted Therapies (SDNTT)
  NCT01706692 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study Adalimumab for Psoriasis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.